UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFBS
1376
ServisFirst Bancshares
SFBS
$4.84B
| $2.54M | ﹤0.01% |
36,901
-1,011
| -3% | -$75.5K |
|
1377
Alcon
ALC
$35.9B
| $2.53M | ﹤0.01% |
36,977
-7,026
| -16% | -$448K |
|
1378
Gentherm
THRM
$1.27B
| $2.53M | ﹤0.01% |
38,823
+319
| +0.8% | +$20.6K |
|
|
PRFT
1379
DELISTED
Perficient Inc
PRFT
| $2.53M | ﹤0.01% |
36,216
| – | – |
|
|
VRNT
1380
DELISTED
Verint Systems
VRNT
| $2.52M | ﹤0.01% |
69,540
+1,824
| +3% | +$65.8K |
|
1381
Delek US
DK
$3.72B
| $2.52M | ﹤0.01% |
93,440
+499
| +0.5% | +$14.7K |
|
|
MDRX
1382
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.52M | ﹤0.01% |
142,962
-9,164
| -6% | -$154K |
|
1383
Nabors Industries
NBR
$1.33B
| $2.52M | ﹤0.01% |
16,269
+4,419
| +37% | +$659K |
|
1384
Virtu Financial
VIRT
$4.92B
| $2.52M | ﹤0.01% |
123,407
-7,440
| -6% | -$162K |
|
1385
John Wiley & Sons Class A
WLY
$2.62B
| $2.5M | ﹤0.01% |
62,453
+8,869
| +17% | +$371K |
|
|
CIVI
1386
DELISTED
Civitas Resources
CIVI
| $2.49M | ﹤0.01% |
42,999
| – | – |
|
1387
Viavi Solutions
VIAV
$9.18B
| $2.49M | ﹤0.01% |
236,932
+4,293
| +2% | +$51.7K |
|
1388
Viasat
VSAT
$11.7B
| $2.48M | ﹤0.01% |
78,303
-103
| -0.1% | -$3.6K |
|
1389
Vaxcyte
PCVX
$8.67B
| $2.48M | ﹤0.01% |
51,681
+17,053
| +49% | +$669K |
|
1390
Blackbaud
BLKB
$2.09B
| $2.48M | ﹤0.01% |
42,059
+686
| +2% | +$38.4K |
|
1391
Coca-Cola Consolidated
COKE
$12.4B
| $2.47M | ﹤0.01% |
48,200
+1,060
| +2% | +$50.7K |
|
1392
Hamilton Lane
HLNE
$5.53B
| $2.47M | ﹤0.01% |
38,592
-1,327
| -3% | -$88.3K |
|
1393
Deluxe
DLX
$1.12B
| $2.45M | ﹤0.01% |
144,456
-4,498
| -3% | -$80K |
|
1394
Eastern Bankshares
EBC
$5.25B
| $2.45M | ﹤0.01% |
142,044
+5,398
| +4% | +$103K |
|
1395
Seacoast Banking Corp of Florida
SBCF
$3.37B
| $2.44M | ﹤0.01% |
78,390
+7,243
| +10% | +$230K |
|
1396
Banner Corp
BANR
$2.43B
| $2.43M | ﹤0.01% |
38,436
| – | – |
|
1397
Transmedics
TMDX
$3.07B
| $2.42M | ﹤0.01% |
39,222
+8,385
| +27% | +$446K |
|
1398
Trinity Industries
TRN
$2.3B
| $2.41M | ﹤0.01% |
81,612
-4,553
| -5% | -$127K |
|
1399
Evolent Health
EVH
$444M
| $2.41M | ﹤0.01% |
85,748
+1,205
| +1% | +$34.5K |
|
1400
Dillards
DDS
$9.9B
| $2.4M | ﹤0.01% |
7,433
-1,162
| -14% | -$378K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.